Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—A systematic review and meta-analysis

Journal of the European Academy of Dermatology and Venereology | Feb 14, 2020 Clinical Pharmacology

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

JAMA | Feb 13, 2020 Clinical Pharmacology

Comparison of biologics and oral treatments for plaque psoriasis

JAMA | Feb 12, 2020 Clinical Pharmacology

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Journal of the American Academy of Dermatology | Feb 10, 2020 Clinical Pharmacology

Pediatric androgenetic alopecia: A review

Journal of the American Academy of Dermatology | Feb 10, 2020 Clinical Pharmacology

Adjusted treatment comparisons between guselkumab and ustekinumab for treatment of moderate-to-severe plaque psoriasis: The COMPASS analysis

British Journal of Dermatology | Feb 04, 2020 Clinical Pharmacology

A phase II, open label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain

Journal of Investigative Dermatology | Feb 03, 2020 Clinical Pharmacology

Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study

Journal of Investigative Dermatology | Feb 03, 2020 Clinical Pharmacology

Immune-related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single-center retrospective study in Japan

The Journal of Dermatology | Jan 31, 2020 Clinical Pharmacology

Growth factor concentrations in platelet rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo controlled, pilot study

Experimental Dermatology | Jan 30, 2020 Clinical Pharmacology

« Prev 1 … 37 38 39 40 41 … 92 Next »

Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—A systematic review and meta-analysis

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

Comparison of biologics and oral treatments for plaque psoriasis

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Pediatric androgenetic alopecia: A review

Adjusted treatment comparisons between guselkumab and ustekinumab for treatment of moderate-to-severe plaque psoriasis: The COMPASS analysis

A phase II, open label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain

Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study

Immune-related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single-center retrospective study in Japan

Growth factor concentrations in platelet rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo controlled, pilot study

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—A systematic review and meta-analysis

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

Comparison of biologics and oral treatments for plaque psoriasis

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Pediatric androgenetic alopecia: A review

Adjusted treatment comparisons between guselkumab and ustekinumab for treatment of moderate-to-severe plaque psoriasis: The COMPASS analysis

A phase II, open label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain

Apremilast in combination to narrowband UVB in the treatment of vitiligo. A 52 weeks monocentric prospective randomized placebo-controlled study

Immune-related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single-center retrospective study in Japan

Growth factor concentrations in platelet rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo controlled, pilot study

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic